DHL Supply Chain announced on Feb. 13 via a press release, a $200 million investment dedicated to expanding its life sciences and healthcare capabilities. The organization says that they will be building new warehouse facilities and investing in new warehouse technologies.
The press release states that “DHL Supply Chain currently has 35 warehouse facilities dedicated to serving their life sciences customers. With the investment they will grow their network to 40 sites by the end of the year. New warehouses will be built in Pennsylvania and North Carolina, which the company has identified as strategic markets that will help them to better serve the healthcare industry. The new facilities in Pennsylvania will position the company within close proximity to major pharmaceutical hubs and research institutions, enabling faster and more efficient distribution of critical products. Meanwhile the North Carolina facilities will cater to the growing demand for life sciences logistics in the southeast region, offering proximity to major airports and transportation infrastructure.”
According to the press release, the expansion is a response to “an upsurge in the pharmaceutical landscape,” especially weight management and diabetes treatments. Additionally, the revival of domestic drug production has caused a demand for more capacity.
DHL Supply Chain also said it would be investing in technologies such as automated guided vehicles and autonomous robots, optimization of network inventory, and temperature-controlled environments.
“Resilient life sciences and healthcare supply chains are critical to the well-being of communities around the world,” said Jim Saponaro, President of Life Sciences and Healthcare, DHL Supply Chain. “This significant investment reflects our commitment to providing the industry with the reliable, efficient, and temperature-controlled logistics solutions that’s needed to deliver life-saving treatments and products to patients in need.”
DHL has the press release.
